Management of Itching with Hives Around a Bite Wound in HIV Patient on ART
Immediate Assessment: Rule Out Severe Cutaneous Adverse Reactions
The priority is to exclude Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), or DRESS syndrome, which require immediate hospitalization. 1, 2
- Check for mucosal involvement (mouth ulcers, conjunctivitis, genital lesions), blistering, skin exfoliation, or epidermal detachment 1, 2
- Measure temperature—fever >39°C indicates severe hypersensitivity requiring immediate drug cessation 1, 2
- Assess for systemic symptoms: lymphadenopathy, hepatitis, or other organ involvement suggesting DRESS syndrome 1, 2
- Calculate body surface area involvement: <10% suggests SJS, 10-30% overlap syndrome, >30% TEN 1
Most Likely Diagnosis: Localized Allergic Reaction to Bite
This presentation is most consistent with a localized hypersensitivity reaction to the bite itself, not antiretroviral-induced drug hypersensitivity. 1, 2
- Antiretroviral hypersensitivity typically occurs within 1-6 weeks of starting therapy, not after stable treatment 1, 2
- Rash or fever occurring >3 months after ART initiation is almost always due to another cause 1
- Localized urticaria around a bite wound one week post-injury suggests delayed-type hypersensitivity to bite antigens 2, 3
Immediate Management Algorithm
Step 1: Wound Care and Local Treatment
- Wash the bite area with soap and water 1
- Apply topical hydrocortisone 1% cream to affected areas 3-4 times daily 4
- Use topical emollients to prevent xerosis, which is common in HIV patients and exacerbates pruritus 1, 5
Step 2: Systemic Antipruritic Therapy
- Prescribe non-sedating oral antihistamines (cetirizine 10 mg daily or loratadine 10 mg daily) for symptomatic relief 1, 2
- Avoid sedating antihistamines in elderly patients due to fall and cognitive impairment risk 2
Step 3: Consider HIV-Specific Pruritus Management
- If pruritus persists despite standard treatment, consider indomethacin 25 mg three times daily orally, which has proven more effective than sedating antihistamines for HIV-associated pruritus 1, 6
- Monitor for gastric intolerance with indomethacin use 1, 6
- Consider gastroprotection with proton pump inhibitors in high-risk patients 6
Laboratory Workup
Obtain baseline studies to assess for systemic involvement and rule out alternative diagnoses: 2
- Complete blood count (check for eosinophilia suggesting DRESS or parasitic infection) 1
- Comprehensive metabolic panel (assess liver function for drug-induced hepatotoxicity) 1, 2
- HIV viral load (degree of pruritus in HIV often correlates with viral load) 1, 5
Exclude Alternative Diagnoses
Scabies
- Always consider scabies in HIV patients, which can present with severe pruritus and minimal skin signs 1
- If suspected, treat with permethrin 5% cream applied from neck down, washed off after 8-14 hours 1
Pediculosis
- Examine for lice or nits if pruritus extends beyond bite area 1
- Treat with permethrin 1% cream rinse applied for 10 minutes if confirmed 1
Drug Hypersensitivity
- Review all medications started within the past 6 weeks, including over-the-counter drugs and herbal remedies 1, 2
- Discontinue any recently added medications if drug reaction suspected 1, 2
Critical Pitfalls to Avoid
- Never rechallenge with a suspected causative agent if drug hypersensitivity is confirmed—reactions occur sooner and can be fatal 1, 2
- Never use prophylactic corticosteroids or antihistamines when restarting medications known to cause rash 2, 3
- Do not apply caustic agents (bleach) or inject antiseptics into the wound 1
- Avoid expressing fluid by squeezing the wound, as this does not reduce infection risk 1
Monitoring and Follow-Up
- Monitor weekly until symptoms resolve 2
- Return immediately if fever develops, mucosal involvement appears, blistering occurs, or systemic symptoms emerge 1, 2, 3
- If no improvement after 2 weeks of appropriate treatment, refer to dermatology 2
- Consider infectious disease consultation if pruritus is generalized and persistent, as this may indicate inadequate HIV control 1, 5
When to Continue vs. Discontinue ART
Continue current ART regimen unless there is evidence of severe cutaneous adverse reaction with systemic involvement. 1